(Q43127559)

14 November 2017

Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer (English)

1 reference

14 November 2017

multiple drug resistance

1 reference

H-W Xu

1

1 reference

14 November 2017

L Xu

2

1 reference

14 November 2017

J-H Hao

3

1 reference

14 November 2017

C-Y Qin

4

1 reference

14 November 2017

H Liu

5

1 reference

14 November 2017

language of work or name

1 reference

1 January 2010

1 reference

Journal of International Medical Research

14 November 2017

1 reference

14 November 2017

38

1 reference

14 November 2017

1

1 reference

14 November 2017

34-42

1 reference

Gastric cancer: standards for the 21st century

14 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Chemotherapy in gastric cancer: a never ending saga.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

The biochemistry of P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

DNA topoisomerases: structure, function, and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

An overview of cancer multidrug resistance: a still unsolved problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

Inhibition of P-glycoprotein function and expression by kaempferol and quercetin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800104

10.1177/147323001003800104

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference